Limited Competition for Continuation of Induced Pluripotent Stem Cell (iPSC) Resources promoting Translational Research Advancements in Neurodegenerative Diseases (U24)
Post Date
April 14th 2011
Application Due Date
June 22nd 2011
Funding Opportunity Number
RFA-NS-11-011
CFDA Number(s)
93.853
Funding Instrument Type(s)
Cooperative Agreement
Funding Activity Categories
Eligibility Categories
Other Eligible Applicants include the following: Foreign (non-U.S.) components of U.S. Organizations are allowed.
Funding
-
Award Range:
$None - $1000000
Grant Description
The National Institute of Neurological Disorders and Stroke (NINDS) invites applications for a limited competition Funding Opportunity Announcement (FOA) utilizing a Cooperative Agreement (U24) to provide continuing support for consortia originally funded through the American Recovery and Reinvestment Act of 2009 (ARRA) to develop well characterized, broadly available induced pluripotent stem cell (iPSC) resources for neurodegenerative diseases. A primary goal of this new initiative is to facilitate the scientific evaluation of iPSC resources for drug discovery purposes and to increase the number of lines, types of mutations, reporter modifications, maintenance and differentiation protocols and cell line characterization that are broadly available to the community as research resources. This Initiative is intended to be a partnership with government, non-government organizations and pharmaceutical companies interested in advancing drug discovery efforts for neurodegenerative diseases.
Contact Information
-
Agency
Department of Health and Human Services
-
Office:
National Institutes of Health
-
Agency Contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV -
Agency Mailing Address:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
- Agency Email Address:
-
More Information:
http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-11-011.html
Get A Free Grant Assistance Kit
To start your application for a free grant package go to: